Geneva Partners’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-9,406
Closed -$229K 92
2018
Q3
$229K Sell
9,406
-11,573
-55% -$282K 0.18% 82
2018
Q2
$511K Sell
20,979
-5,225
-20% -$127K 0.41% 63
2018
Q1
$642K Buy
26,204
+1,515
+6% +$37.3K 0.53% 54
2017
Q4
$617K Buy
24,689
+7,625
+45% +$191K 0.46% 64
2017
Q3
$431K Buy
+17,064
New +$431K 0.34% 71
2016
Q2
$395K Buy
+15,702
New +$395K 0.35% 66

Other funds holding IBDN

Geneva Partners's IBDN Position: Q4 2018 in Review

Geneva Partners sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2018, closing a stake of 9,406 shares — an estimated $229K sold.

Geneva Partners first reported a position in IBDN in Q2 2016 and held it in 6 quarters. The position peaked at $642K in Q1 2018. 110 funds tracked by Wall St. Rank hold IBDN as of Q4 2018.

  • Geneva Partners reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2018 after selling out during the quarter.
  • Geneva Partners sold 9,406 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2018, an estimated $229K.
  • Geneva Partners first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q2 2016 and held it in 6 quarters.
  • Geneva Partners's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $642K in Q1 2018.
  • 110 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2018.

Based on Geneva Partners's 13F filing for Q4 2018, filed 30 Jan 2019.